Given the wide-ranging reasons for vaccine hesitancy, there is a strong need for evidence-based, community-informed vaccine resources, especially for people affected by sickle cell disease who are susceptible to infections.

Through its Vaccine Equity in (VES) Sickle Cell Disease Study, the SCAGO worked with patients with sickle cell disease, their families, caregivers, and clinicians to co-design and implement a Vaccination Equity Strategy for people affected by sickle cell disease.

The strategy was created to support policymakers, healthcare agencies and providers, hospitals, etc. with valuable insights to achieve vaccine equity and support the sickle cell disease community with fact-based vaccine information.